Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified

被引：41

作者：

Zinzani, Pier Luigi ^{[1
]}

Pellegrini, Cinzia ^{[1
]}

Broccoli, Alessandro ^{[1
]}

Stefoni, Vittorio ^{[1
]}

Gandolfi, Letizia ^{[1
]}

Quirini, Federica ^{[1
]}

Argnani, Lisa ^{[1
]}

Berti, Emilio ^{[2
]}

Derenzini, Enrico ^{[1
]}

Pileri, Stefano ^{[1
]}

Baccarani, Michele ^{[1
]}

机构：

[1] Univ Bologna, Inst Hematol & Med Oncol L&A Seragnoli, I-40138 Bologna, Italy

[2] Univ Milano Bicocca, IRCCS Osped Maggiore, Milan, Italy

来源：

LEUKEMIA & LYMPHOMA | 2011年 / 52卷 / 08期

关键词：

GEMCITABINE; REGIMEN;

D O I：

10.3109/10428194.2011.573031

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1585 / 1588

页数：4

共 50 条

[41] Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma
Campbell, Peter
Thomas, Christan M.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (02) : 143 - 147
[42] Emerging Therapies in Relapsed and Refractory Peripheral T-Cell Lymphoma
Bachow, Spencer H.
O'Connor, Owen A.
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (12) : 837 - 846
[43] Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma
Rashidi, Armin
Cashen, Amanda F.
FUTURE ONCOLOGY, 2015, 11 (11) : 1659 - 1664
[44] Therapeutic Advances in Relapsed and Refractory Peripheral T-Cell Lymphoma
Stuver, Robert
Moskowitz, Alison J.
CANCERS, 2023, 15 (03)
[45] Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
Coiffier, Bertrand
Federico, Massimo
Caballero, Dolores
Dearden, Claire
Morschhauser, Franck
Jaeger, Ulrich
Truemper, Lorenz
Zucca, Emanuele
da Silva, Maria Gomes
Pettengell, Ruth
Weidmann, Eckhart
d'Amore, Francesco
Tilly, Herve
Zinzani, Pier Luigi
CANCER TREATMENT REVIEWS, 2014, 40 (09) : 1080 - 1088
[46] Sobuzoxane-Containing Regimens Show Promising Response As Salvage Therapy for Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL) and Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL-NOS)
Shimizu, Ikuo
Takeda, Wataru
Kirihara, Takehiko
Sato, Keijiro
Fujikawa, Yuko
Ueki, Toshimitsu
Hiroshima, Yuki
Sumi, Masahiko
Ueno, Mayumi
Ichikawa, Naoaki
Kobayashi, Hikaru
BLOOD, 2012, 120 (21)
[47] Gemcitabine, dexamethasone, and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma-not otherwise specified
Qi, Fei
Dong, Mei
He, Xiaohui
Li, Yexiong
Wang, Weihu
Liu, Peng
Yang, Jianliang
Gui, Lin
Zhang, Changgong
Yang, Sheng
Zhou, Shengyu
Shi, Yuankai
ANNALS OF HEMATOLOGY, 2017, 96 (02) : 245 - 251
[48] COMPOSITE LYMPHOMA COMPRISING PERIPHERAL T-CELL LYMPHOMA NOT OTHERWISE SPECIFIED AND B-CELL FOLLICULAR LYMPHOMA
Kolagatla, S.
Chaudhary, S.
Moka, N.
JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 554 - 554
[49] Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified
Kawamoto, Keisuke
Miyoshi, Hiroaki
Yanagida, Eriko
Yoshida, Noriaki
Kiyasu, Junichi
Kozai, Yasuji
Morikita, Tatsuma
Kato, Takeharu
Suzushima, Hitoshi
Tamura, Shinobu
Muta, Tsuyoshi
Kato, Koji
Eto, Tetsuya
Seki, Ritsuko
Nagafuji, Koji
Sone, Hirohito
Takizawa, Jun
Seto, Masao
Ohshima, Koichi
EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (05) : 459 - 466
[50] Peripheral T-Cell Lymphoma, Not Otherwise Specified: Clinical Manifestations, Diagnosis, and Future Treatment
Pileri, Stefano A.
Tabanelli, Valentina
Fiori, Stefano
Calleri, Angelica
Melle, Federica
Motta, Giovanna
Lorenzini, Daniele
Tarella, Corrado
Derenzini, Enrico
CANCERS, 2021, 13 (18)

← 1 2 3 4 5 →